Collaborations

Agreement made for development of key cancer treatment component

Published in Cancer Weekly, January 13th, 2004

ProMetic Life Sciences (PLI) announced that its wholly owned U.K. subsidiary, ProMetic BioSciences Ltd, has entered into an exclusive worldwide agreement with Mitra Medical Technology AB for the manufacture and supply of the key component of their new medical device Mitradep, developed for use in the area of cancer therapy and cancer diagnosis.

This key component is to be manufactured by ProMetic at its production facilities on the Isle of Man, U.K.

"ProMetic is proud to be associated with this project which will benefit all parties involved and substantially improve the quality of life for cancer patients," affirmed Pierre Laurin, president and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-01-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry